MASSACHUSETTS GENERAL HOSPITAL
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Study of TNF-Antagonism in the Metabolic Syndrome (II)
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00413400
- Locations
- ๐บ๐ธ
MGH, Boston, Massachusetts, United States
Metabolic Effects of Switching Kaletra to Boosted Reyataz
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-03-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00413153
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT00411047
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2009-09-22
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT00409344
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Study of TNF-Antagonism in Metabolic Syndrome
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT00409318
- Locations
- ๐บ๐ธ
MGH, Boston, Massachusetts, United States
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2006-11-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT00403533
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Lifestyle Modification and Metformin Use in the Treatment of HIV
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00399360
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 624
- Registration Number
- NCT00392756
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT00392665
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
Study of Functional Microarray-Facilitated Lidocaine Liposomal Cream Absorption for Cutaneous Anesthesia in Volunteers
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2009-02-26
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00387296
ยฉ Copyright 2024. All Rights Reserved by MedPath